A Meta-Analysis of Adalimumab for Fistula in Crohn’s Disease

Table 2

Complete closure rate of ADA treatment on CD and fistula.

Trials	Therapy weeks	Complete closure fistula rate
Colombel et al.	56 w	40%
Lichtiger et al.	24 w	40.9%
Dewint et al.	24 w	33%
Castano-Milla et al.	12 m	41%
Hinojosa et al.	4 w	23%
Panaccione et al.	24 w	40%
Rizzello et al.	24 w	24%